BRITTANY KING: Open Payments
NPI 1427441815 · BLOOMINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 44 payments from 11 companies in 2025. Trend: 2023 $271 · 2024 $588 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 21 | $325 |
| ABBVIE INC. | 3 | $83 |
| Novo Nordisk Inc | 4 | $78 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $73 |
| Organon LLC | 3 | $68 |
| Biogen, Inc. | 3 | $53 |
| Astellas Pharma US Inc | 2 | $33 |
| Lilly USA, LLC | 1 | $25 |
| Dexcom, Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: GEMTESA, MYFEMBREE, UBRELVY, Wegovy, NEXPLANON, ZURZUVAE, Veozah, MOUNJARO.
Industry payments across IL — which companies pay providers there.
